Quarterly ResultAug 3, 2026, 04:34 PM
BWX Technologies Q2 Revenue $901.6M, EPS $0.97; Raises 2026 Guidance
AI Summary
BWX Technologies reported strong second-quarter 2026 results, with revenues increasing 18% to $901.6 million and GAAP diluted EPS rising 14% to $0.97. The company exceeded expectations, driven by significant growth in Commercial Operations. Reflecting this performance and the recent acquisition of Precision Components Group, BWXT raised its full-year 2026 financial guidance for adjusted EBITDA, non-GAAP EPS, and free cash flow. Additionally, BWXT announced the sale of its medical business to focus on core nuclear markets.
Key Highlights
- Q2 2026 revenues increased 18% to $901.6 million from $764.0 million in Q2 2025.
- Q2 2026 GAAP diluted EPS rose 14% to $0.97 from $0.85 in Q2 2025.
- Q2 2026 net income was $89.1 million, up 14% from $78.5 million in Q2 2025.
- Raised 2026 adjusted EBITDA guidance to $662 million-$672 million.
- Raised 2026 non-GAAP EPS guidance to $4.70-$4.80.
- Raised 2026 free cash flow guidance to $345 million-$360 million.
- Announced the sale of the medical business to focus on core nuclear markets.
- Closed the acquisition of Precision Components Group (PCG) on July 1, 2026.
- Commercial Operations revenue grew 72% to $302.5 million in Q2 2026.
Price Impact
More from BWXT